miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer

Area of Science:

• Molecular biology
• Cancer research
• Genetics

Background:

• MicroRNAs (miRNAs) are crucial regulators of gene expression in various biological processes, including cancer.
• The human mutS homolog 2 (hMSH2) gene, a key component of DNA mismatch repair, is implicated in lung cancer development.
• Dysregulation of miRNA and hMSH2 expression is observed in lung cancer, suggesting a potential link.

Purpose of the Study:

• To investigate the regulatory role of miR-21 on hMSH2 gene expression in lung cancer.
• To determine the impact of miR-21 on lung cancer cell proliferation and cell cycle progression.
• To elucidate the mechanism by which miR-21 influences hMSH2 and cancer cell behavior.

Main Methods:

• Bioinformatic prediction and luciferase assays were employed to identify and validate hMSH2 as a direct target of miR-21.
• MiRNA mimics and inhibitors were used to manipulate miR-21 levels, and gene expression was quantified using RT-PCR and Western blotting.
• Cell proliferation was assessed via MTT and real-time cell analysis, while cell cycle distribution was analyzed by flow cytometry.

Main Results:

• A significant inverse correlation was observed between miR-21 and hMSH2 expression in human lung cancer cell lines.
• Upregulation of miR-21 promoted cell proliferation and increased the proportion of cells in the S phase of the cell cycle.
• Conversely, knockdown of miR-21 led to cell cycle arrest at the G2/M phase and inhibited cell proliferation.

Conclusions:

• MiR-21 acts as a key regulator of hMSH2 expression in lung cancer.
• MiR-21 modulates lung cancer cell proliferation and cell cycle progression by targeting hMSH2.
• These findings highlight miR-21 as a potential therapeutic target for lung cancer treatment.